-Outlook As the Manmohan Singh government makes evident its unfriendliness to villages, the nation hurtles towards disaster. It's a danger no one wants to face. Prime Minister Manmohan Singh has been trying for years to make us believe that agriculture is a vast marshland in which a huge population is stuck ankle- to neck-deep and it is his duty to rescue them. "Our salvation lies in moving people out of agriculture," he...
More »SEARCH RESULT
Total Matching Records found : 283
Home to Facebook and Google, Hyderabad has no answer on tackling toilet waste -Rahul Devulapalli
-The Times of India HYDERABAD: Home to Asia's first office of Facebook and Google's first in India, these companies have put Hyderabad right on top of the global map by providing zillions of solutions worldwide from the city, but when it comes to their own toilet waste, they apparently have no clue where it is heading. With very few sewerage treatment plants (STP) working properly, waste flowing from the toilets of hundreds...
More »Are ‘improved stoves’ good enough?-N Gopal Raj
-The Hindu There is little demonstrated evidence of health benefits from access to ‘improved' stoves and clean fuels Around three billion of the world's poorest people have to burn firewood, animal dung, crop waste and coal to cook food and heat homes, using traditional stoves and open fires. The health-damaging smoke that results is estimated to cause some four million premature deaths each year, principally of women and children. Although many governments, multinational...
More »Drugs, Ranbaxy and lies
-The Hindu Seven years after the first warning in June 2006 from the U.S. Food and Drug Administration (FDA) and five years after the Department of Justice initiated legal proceedings against the company, Ranbaxy is back in the news for the same wrong reasons. Last fortnight it pleaded guilty to felony charges in the U.S., admitting to selling adulterated drugs with intent to defraud, not reporting that its drugs failed...
More »Ranbaxy case may take a toll on other Indian drug makers
-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »
